Company Performance Metrics
- Jianfu Wang: Founder & CEO
- Jean-Luc Henrioul: Business Development, Europe, MOHS surgery
Novodiax is a biotech startup dedicated to advancing cancer and autoimmunity diagnostics through innovative rapid immunoassays.
Our revolutionary ihcDirect® assays are listed for in vitro diagnostic (IVD) use and provide immunohistochemistry (IHC) results in as little as 10 minutes on frozen tissues! They also provide workflow benefits for
formalin-fixed, paraffin-embedded (FFPE) tissues, helping reduce assay time by up to 40-60 minutes.
ihcDirect works by directly conjugating primary antibodies to our proprietary and sensitive polymerized horseradish peroxidase (polyHRP) detection system, thus delivering immunoassays for histology and cytology (2020) that: - Are lightning fast (~10 minutes) - Require minimal lab space and no specialized equipment - Can be performed at room temperature - Are simple to perform like H&E tests, yet provide the sensitivity and specificity of immunoassays
Our assays are also perfect for helping you advance your research (see our ihcPrime™ and Q-Stain® products and custom services), develop cutting edge companion diagnostics (CDx), and more. Let’s partner together to make that happen!
Visit our website or contact us to learn more. www.novodiax.com sales@novodiax.com
